Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ANRO
Stock Latest News
Ratings
Buy Recommendation for Alto Neuroscience Driven by Promising ALTO-207 Acquisition and Strategic Financial Backing
15h ago
ANRO
Premium
Company Announcements
Alto Neuroscience’s ALTO-101 Study: A Potential Game-Changer for Schizophrenia Treatment?
3d ago
ANRO
Premium
Company Announcements
Alto Neuroscience’s ALTO-300 Study: A Potential Game-Changer in Depression Treatment
3d ago
ANRO
Premium
Company Announcements
Alto Neuroscience’s ALTO-100 Study: A Potential Game-Changer for Bipolar Disorder Treatment?
3d ago
ANRO
Premium
Ratings
Alto Neuroscience’s Strategic Advancements and Regulatory Milestones Justify Buy Rating
7d ago
ANRO
Premium
The Fly
Alto Neuroscience price target raised to $50 from $10 at H.C. Wainwright
7d ago
ANRO
Premium
The Fly
Alto Neuroscience price target raised to $16 from $10 at Baird
10d ago
ANRO
Premium
Company Announcements
Alto Neuroscience Secures $50M in Private Placement
10d ago
8K
ANRO
Premium
Ratings
Alto Neuroscience, Inc.: Accelerated Drug Development and Strong Clinical Trial Compliance Drive Buy Rating
10d ago
ANRO
Premium
The Fly
Midday Fly By: AWS hit by outage, Kering sells beauty unit
10d ago
BA
DX
Premium
Ratings
Alto Neuroscience, Inc.: Strategic Advancements and Financial Strength Drive Buy Rating
10d ago
ANRO
Premium
The Fly
Alto Neuroscience price target raised to $16 from $10 at Baird
10d ago
ANRO
Premium
The Fly
Alto Neuroscience to sell 3.832M shares at $5.91 in private placement
11d ago
ANRO
Premium
The Fly
Alto Neuroscience plans to accelerate development of ALTO-207
11d ago
ANRO
Premium
Ratings
Optimistic Buy Rating for Alto Neuroscience, Inc. Amidst Promising Developments and FDA Fast Track Designation
24d ago
ANRO
Premium
The Fly
Morning Movers: Apple shares slip following Jefferies downgrade
27d ago
GME
RUM
Premium
The Fly
Alto Neuroscience granted fast track designation for ALTO-101
27d ago
ANRO
Premium
The Fly
Alto Neuroscience initiated with a Buy at Chardan
1M ago
ANRO
Premium
Ratings
Innovative Biomarker Strategy and Promising Pipeline Drive Buy Rating for Alto Neuroscience
1M ago
ANRO
Premium
Ratings
Innovative Precision Psychiatry and Strong Financials Justify Buy Rating for Alto Neuroscience
2M ago
ANRO
Premium
The Fly
Alto Neuroscience announces results from replication study
2M ago
ANRO
Premium
Ratings
Promising Pipeline and Expert Backing Drive Buy Rating for Alto Neuroscience, Inc.
2M ago
ANRO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.